Top compounds associated with response to LMNB2


Feature Type Standardized
Nominal ANOVA
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.092 0.008
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.094 0.008
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.008
mRNA ML311 CTRPv2 pan-cancer AAC 0.086 0.009
mRNA lapatinib CTRPv2 pan-cancer AAC -0.096 0.009
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.089 0.009
mRNA KPT185 CTRPv2 pan-cancer AAC 0.1 0.009
mRNA tigecycline CTRPv2 pan-cancer AAC 0.13 0.009
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.01
mRNA AZD0530 CCLE pan-cancer AAC 0.12 0.01
Download CSV